Novel Sonoporation Platform for Gene Transfection, Drug Targeting and Sonodynamic Therapy for Cancer

Novel Sonoporation Platform for Gene Transfection, Drug Targeting and Sonodynamic Therapy for Cancer

The
SONIDEL SP100
Sonoporation Platform

Is optimised for the following applications:

  • Gene Transfection/Sonoporation
    • Non-invasive stimulation of gene transfer
    • Efficient gene/nucleic acid transfer
    • In vivo and in vitro applications
    • Compatible for use with plasmids and minicircle DNA
    • Precludes viral transfection and associated challenges
    • Reduced contamination risk
    • Minimal impact on cell/tissue viability
    • Compatible range of accessories including microbubble preparations (MB101) and Positive Control Kit (STK10)
    • Photographic Results
  • Drug Targeting – enhancing Cancer Chemotherapeutics
    • Exploiting ultrasound-mediated transient cell-membrane permeabilisation
    • Exploiting ultrasound-mediated tissue dispersion (recently demonstrated)
    • Proven to enhance the cytotoxicity of cancer chemotherapeutic agents in vitro and in vivo
    • Site-specific targeting of cytotoxic effects by application of ultrasound to the target site
    • Non-invasive stimulation of targeted effects
    • Publications
  • Sonodynamic Therapy for Cancer
    • SP100 Platform is adaped for activation of sonodynamic agents
    • Site specific targeted cytotoxic effects for the treatment of solid tumors
    • Non-invasive activation of the sonodynamic agents
    • Non-invasive targeting of cytotoxic effects Sonodynamic Therapy
    • Publications

SONIDEL SP100 Sonoporator …………………………………………….SONIDEL MB101 Microbubble

SONIDEL STK10 Transfection Kit ………………………………………Full Sonoporation Publication List

Comments are closed.